Gainplan’s Verastem VSTM Stock Holding History

Gainplan’s Portfolio VSTM Stock Details VSTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-2,208	Closed	-$55K	–	14
2017 Q1	$55K	Buy	+2,208	New	+$35.1K	0.04%	12

Other funds holding VSTM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

DVC

Deer VII & Co Larchmont, New York $317M AUM 30.89% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $52.8B AUM 58.98% 1-Year Est. Return

HCM

Howland Capital Management Boston, Massachusetts $2.77B AUM 19.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Gainplan's VSTM Position: Q2 2017 in Review

Gainplan sold out of Verastem (VSTM) in Q2 2017, closing a stake of 2,208 shares — an estimated $55K sold.

Gainplan first reported a position in VSTM in Q1 2017 and held it in 1 quarter. The position peaked at $55K in Q1 2017. 59 funds tracked by Wall St. Rank hold VSTM as of Q2 2017.

Gainplan reported no remaining Verastem position as of Q2 2017 after selling out during the quarter.
Gainplan sold 2,208 Verastem shares in Q2 2017, an estimated $55K.
Gainplan first reported a position in Verastem in Q1 2017 and held it in 1 quarter.
Gainplan's Verastem position peaked at $55K in Q1 2017.
59 funds tracked by Wall St. Rank held Verastem as of Q2 2017.

Based on Gainplan's 13F filing for Q2 2017, filed 2 Aug 2017.